Literature DB >> 22294127

Primary observation (Irwin) test in rodents for assessing acute toxicity of a test agent and its effects on behavior and physiological function.

Sylvain Roux1, Evelyne Sablé, Roger D Porsolt.   

Abstract

The Irwin observation test is commonly used to evaluate the effects of a new substance on behavior and physiological function. The results of the Irwin test are used to determine potential toxicity and to select doses for specific therapeutic activity. The Irwin test can also be used in a safety approach for detecting untoward effects of a new compound on general behavior and for evaluating its acute neurotoxicity. In particular, data obtained in the Irwin Test can help to determine the dose range to be tested in other safety tests. Furthermore, the Irwin Test can furnish a first but pertinent orientation towards a specific therapeutic indication, a specific mechanism of action or a specific physiological function.

Entities:  

Mesh:

Year:  2005        PMID: 22294127     DOI: 10.1002/0471141755.ph1010s27

Source DB:  PubMed          Journal:  Curr Protoc Pharmacol        ISSN: 1934-8282


  25 in total

1.  Therapeutic effect of Saraca asoca (Roxb.) Wilde on lysosomal enzymes and collagen metabolism in adjuvant induced arthritis.

Authors:  Subramanian Saravanan; Narasimhan Prakash Babu; Perumal Pandikumar; Savarimuthu Ignacimuthu
Journal:  Inflammopharmacology       Date:  2011-09-23       Impact factor: 4.473

2.  Antiproliferative and toxicological properties of methanolic extract obtained from Solanum capsicoides All. seeds and carpesterol.

Authors:  Marcel Petreanu; Ágatha Amanda Alves Guimarães; Milena Fronza Broering; Emili Kamila Ferreira; Isabel Daufenback Machado; Ana Lúcia Tasca Gois; João Ernesto de Carvalho; Franco Delle Monache; Rivaldo Niero; José Roberto Santin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-07-20       Impact factor: 3.000

3.  Glucocorticoid receptor modulators CpdX and CpdX-D3 exhibit the same in vivo antiinflammatory activities as synthetic glucocorticoids.

Authors:  Guoqiang Hua; Naimah Zein; François Daubeuf; Pierre Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-21       Impact factor: 11.205

4.  Suppressing pro-inflammatory prostaglandin signaling attenuates excitotoxicity-associated neuronal inflammation and injury.

Authors:  Jianxiong Jiang; Ying Yu; Erika Reime Kinjo; Yifeng Du; Hoang Phuong Nguyen; Ray Dingledine
Journal:  Neuropharmacology       Date:  2019-02-11       Impact factor: 5.250

5.  Hypolipidemic activity of Symplocos cochinchinensis S. Moore leaves in hyperlipidemic rats.

Authors:  Christudas Sunil; Savarimuthu Ignacimuthu; Chidambaram Kumarappan
Journal:  J Nat Med       Date:  2011-06-18       Impact factor: 2.343

6.  Determination of narcotic potency using a neurobehavioral assay with larval zebrafish.

Authors:  Harry W Broening; Jane La Du; Gregory J Carr; J F Nash; Lisa Truong; Robert L Tanguay
Journal:  Neurotoxicology       Date:  2019-05-11       Impact factor: 4.294

7.  Toxicological study and efficacy of blank and paclitaxel-loaded lipid nanocapsules after i.v. administration in mice.

Authors:  José Hureaux; Frédéric Lagarce; Frédéric Gagnadoux; Marie-Christine Rousselet; Valérie Moal; Thierry Urban; Jean-Pierre Benoit
Journal:  Pharm Res       Date:  2010-03       Impact factor: 4.200

8.  Evaluation of Ceiba pentandra (L.) Gaertner bark extracts for in vitro cytotoxicity on cancer cells and in vivo antitumor activity in solid and liquid tumor models.

Authors:  Ravishankar Kumar; Nitesh Kumar; Grandhi V Ramalingayya; Manganahalli Manjunath Setty; Karkala Sreedhara Rangnath Pai
Journal:  Cytotechnology       Date:  2016-07-25       Impact factor: 2.058

9.  In vivo and in vitro immunomodulatory potential of swertiamarin isolated from Enicostema axillare (Lam.) A. Raynal that acts as an anti-inflammatory agent.

Authors:  S Saravanan; P Pandikumar; N Prakash Babu; V I Hairul Islam; K Thirugnanasambantham; M Gabriel Paulraj; K Balakrishna; S Ignacimuthu
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

10.  Inverse Agonism of Cannabinoid Receptor Type 2 Confers Anti-inflammatory and Neuroprotective Effects Following Status Epileptics.

Authors:  Ying Yu; Lexiao Li; Davis T Nguyen; Suni M Mustafa; Bob M Moore; Jianxiong Jiang
Journal:  Mol Neurobiol       Date:  2020-05-06       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.